STO-609, a potent inhibitor regarding to the Ca2+/CaM signaling pathway and CALM1, suppressed proliferation and migration of NFPA cells via inducing NFPA cells apoptosis. Here, CALM1 is linked to non-functioning pituitary adenoma.